Table 1:

Age, gender, chlorpromazine equivalents of medication (mg), age at onset of psychosis, duration of illness (years) and clinical ratings of individual subjects. The order of the patients is as shown in Figure 2 (i.e., the first bar in these plots corresponds to a 13-year-old female). Mean and standard deviation are depicted in the last row. PSG: polysomnography; CGAS: Children’s Global Assessment Scale (higher score means better overall functioning, i.e. 100 = Superior functioning, 50 = Moderate degree of interference in functioning, 10 = Needs constant supervision); SAPS: Scale for the Assessment of Positive Symptoms (0 = None/Not at all, 1 = Questionable, 2 = Mild, 3 = Moderate, 4 = Marked, 5 = Severe; 34 items).

Patient	Gender	Age at PSG	Medication (mg)	Age at Onset	Duration of Illness (y)	CGAS	SAPS Sum	SAPS Global Rating of Hallucinations
1	Female	13	900	9	4	8	28	3
2	Male	17	1200	5	12.9	33	41	5
3	Female	15	600	11	4.6	35	23	1
4	Female	13	550	11	2.6	36	23	4
5	Female	18	700	9	9.5	35	32	3
6	Female	9	900	8	1.7	22	22	5
7	Male	21	250	11	10.1	55	1	0
8	Male	12	None	11	1.7	10	40	5
9	Female	17	400	10	7.6	35	5	0
10	Female	19	750	12	7.2	45	10	2
11	Female	12	150	9	3.8	40	17	3
12	Female	20	1000	10	10.7	55	20	4
13	Female	15	300	10	5.3	45	0	0
14	Male	21	1300	11	11	50	9	0
15	Female	15	650	11	4.1	45	10	2
16	Female	21	1100	10	11.3	60	54	4
17	Male	14	600	8	6.3	35	36	3
Mean (±SD)		16.00 (±3.64)	709.38 (±340.69)	9.76 (±1.68)	6.73 (±3.63)	37.88 (±14.50)	21.82 (±15.29)	2.59 (±1.84)